Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Sep 15, 2026
AeroVironment (AVAV) and the Path to $200: Assessing +30% Upside Potential

AeroVironment (AVAV) and the Path to $200: Assessing +30% Upside Potential

Key Takeaways

  • The stock price target of $200 implies roughly 30% upside from AeroVironment's recent trading range near $153, following a steep decline from its 52-week high of $417.86.
  • The strongest bullish factors are a record funded backlog of about $1.5 billion, a landmark U.S. Army directed-energy laser contract, and better-than-expected quarterly results.
  • The biggest obstacles include trailing net losses, execution risk around a back-loaded revenue ramp, and lingering governance concerns.
  • Key technical levels to watch are the recent low near $135.20 as support and the $180–$200 zone as the primary resistance area on the way to the target.
  • The $200 level is realistic but not guaranteed; reaching it would likely require sustained margin expansion and continued order momentum.

Why the $200 Mark Matters for Investors

AeroVironment, Inc. (AVAV) specializes in unmanned aircraft systems, loitering munitions like Switchblade, and counter-drone plus directed-energy technologies. Shares climbed above $417 late in 2025 before dropping more than 40% and hovering near the 52-week low of $135.20 through much of 2026. A post-earnings recovery has pushed the stock back into the mid-$150s, prompting fresh discussion on whether it can return to the $200 threshold.

Current Market Snapshot

After releasing fiscal first-quarter results in September 2026, AeroVironment (AVAV) traded around $153, reflecting an approximate 10% gain as the market absorbed the numbers. Revenue reached roughly $480.5 million, ahead of consensus near $456 million, while adjusted EPS came in at $0.59 compared with expectations of about $0.24. The funded backlog hit a record $1.5 billion, up 37% from a year earlier, and the book-to-bill ratio stood at 1.4, pointing to solid demand for counter-UAS and autonomous offerings. Management kept fiscal 2027 guidance intact at $2.125–$2.225 billion in revenue and adjusted EPS of $3.02–$3.34, though most of the activity is expected in the second half.

Potential Catalysts for Further Gains

One standout development is the company’s directed-energy work. In early September 2026 it received a $464.8 million U.S. Army contract for the LOCUST X3 laser weapon system under the Enduring-High Energy Laser program—the first production award of its kind. An initial international LOCUST order followed, hinting at wider market reach. The BlueHalo acquisition has added exposure to space, cyber, and electronic warfare, enlarging the addressable market. Ongoing demand for counter-drone solutions, fueled by battlefield trends, supports a constructive backdrop. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Key Risks That Could Slow Progress

Fundamentals are still mixed. Trailing net losses stand near $265 million with a negative net margin, so the valuation rests on future expectations. The forward P/E in the low-to-mid 40s leaves little margin for error if the second-half ramp falters. Execution and governance issues persist, including a goodwill impairment from a terminated program and a material weakness in internal controls that remains under remediation. A lost U.S. Space Force contract earlier in 2026 highlights award volatility, and negative free cash flow is anticipated in fiscal 2027 as capacity investments continue.

Analyst Views and Price Targets

Wall Street sentiment stays mostly positive despite several target cuts in 2026. The consensus leans toward Buy or Moderate Buy, with average 12-month targets between $224 and $267 and individual figures ranging from $166 to $429. Recent updates include J.P. Morgan lifting its target to $210, Citizens JMP holding at $230, and Raymond James keeping an outperform rating with a $210 objective. The $200 level sits below the consensus average yet above some more cautious estimates, placing it within the range of outcomes analysts currently foresee.

Important Technical Levels

From a technical standpoint, the 52-week low near $135.20 serves as key support where buyers have stepped in repeatedly. On the upside, reclaiming $180 would be the first hurdle before testing $200, which aligns with the lower end of several analyst targets. With a beta around 1.41, the shares tend to move more sharply than the broader market.

Tracking Signals with AI Daily Buy/Sell Signals

Traders following names like AeroVironment (AVAV) can benefit from AI Daily Buy/Sell Signals to stay on top of shifting conditions. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals drawn from market dynamics, technical patterns, and data-driven models. It helps surface fresh ideas, track open positions, and spot emerging trends. I find it useful as a complement to my own review of backlog trends and contract updates.

Overall Outlook

A move toward $200 looks achievable for AeroVironment (AVAV) yet remains uncertain. Support comes from the record backlog, the historic laser contract, and analyst targets that generally exceed that mark. Offsetting factors include ongoing losses, the back-loaded revenue outlook, governance work, and near-term cash-flow pressure. Watching backlog expansion, margin trends, the timing of second-half deliveries, and progress on controls will be key before assuming the stock can hold above $200.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AVAV

AVAV in -0.89% downward trend, sliding for three consecutive days on August 26, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where AVAV declined for three days, in 227 of 316 cases, the price declined further within the following month. The odds of a continued downward trend are 72%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for AVAV moved out of overbought territory on August 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 25 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 69%.

AVAV moved below its 50-day moving average on August 20, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AVAV crossed bearishly below the 50-day moving average on August 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.

AVAV broke above its upper Bollinger Band on September 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AVAV entered a downward trend on September 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 64 cases where AVAV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.

The Momentum Indicator moved above the 0 level on September 14, 2026. You may want to consider a long position or call options on AVAV as a result. In 69 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

The Moving Average Convergence Divergence (MACD) for AVAV just turned positive on September 14, 2026. Looking at past instances where AVAV's MACD turned positive, the stock continued to rise in 39 of 51 cases over the following month. The odds of a continued upward trend are 76%.

Following a +2.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVAV advanced for three days, in 243 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.773) is normal, around the industry mean (6.216). AVAV has a moderately high P/E Ratio (149.026) as compared to the industry average of (55.286). AVAV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.883). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (3.817) is also within normal values, averaging (18.486).

The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. AVAV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 85 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVAV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.75B. The market cap for tickers in the group ranges from 4.49 to 1.95T. SPCX holds the highest valuation in this group at 1.95T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -4%. For the same Industry, the average monthly price growth was -18%, and the average quarterly price growth was -10%. ELMT experienced the highest price growth at 28%, while FJET experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 12%. For the same stocks of the Industry, the average monthly volume growth was -32% and the average quarterly volume growth was -17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 70
Price Growth Rating: 66
SMR Rating: 77
Profit Risk Rating: 74
Seasonality Score: 2 (-100 ... +100)
View a ticker or compare two or three
AVAV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of unmanned aircraft and charging systems

Industry AerospaceDefense

Profile
Details
Industry
Aerospace And Defense
Address
241 18th Street South
Phone
+1 703 418-2828
Employees
4091
Web
https://www.avinc.com
Interact to see
Advertisement
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.
NBIS shares surged approximately +10% in premarket trading on March 11, 2026, from a prior close of $96.32. The primary catalyst is the imminent addition of Nebius Group to the Bloomberg 500 (B500) Index, effective prior to the open of trading on Thursday, March 12, 2026.
ORCL shares surged approximately +10.49% in Wednesday's premarket session, trading around $165.07 versus Tuesday's closing price of $149.40. The primary catalyst is Oracle's Q3 FY2026 earnings beat, with adjusted EPS of $1.79 vs. the $1.70 consensus estimate, and revenue of $17.2 billion topping the $16.92 billion forecast.
Shares of AngloGold Ashanti plc (AU) are down approximately 5.00% in early trading on March 11, 2026, falling from a prior close of $108.26 to around $102.85. The primary driver is a renewed pullback in gold prices, which has weighed heavily on gold mining equities across the board.
HMY shares are trading down approximately 13% in early session trading on March 11, 2026, following the release of the company's H1 FY26 interim results. Revenue of R44.4 billion (~US$2.6 billion) missed analyst consensus estimates of R47.56 billion, a significant shortfall that spooked investors.
FICO fell over 9% today, extending a multi‑week downtrend that has already knocked the stock more than 7% lower since its last earnings update. The decline comes despite strong recent financial results, including double‑digit revenue growth, expanding margins, and repeated earnings beats.
RERE fell roughly 10% today, giving back a portion of its strong gains over the past year and month, as traders reacted to fresh earnings and guidance. The company delivered robust Q4 2025 results, with revenue growth near 30% year over year and earnings per share ahead of consensus estimates, underscoring continued operational momentum.
Top hedge funds like Millennium, Citadel, and Bridgewater showed limited direct accumulation of penny stocks in Q4 2025 13F filings, but rotations into biotech, energy, and defense sectors highlight indirect interest in low-priced plays under $5. New entries and increased positions focused on volatile sectors like biotech (e.g., ABCL) and energy (e.g., AMPY), with full exits from overvalued names signaling a hunt for undervalued pennies amid market uncertainty.
Penny stocks in the oil sector are exploding in trading volume amid a massive oil price rally, with the USO ETF hitting a record $12.4 billion in daily trades—up 1,000% YTD and surpassing peaks from 2020, 2022, and 2025. Geopolitical tensions from the ongoing Iran war are driving oil above $100 per barrel, creating supply shocks and opportunities for high-volatility plays in exploration, drilling, and production.
NTSK shares are trading down approximately 20% in premarket trading on March 12, 2026, following the company's Q4 fiscal 2026 earnings release after the close on March 11. The primary catalyst is not the earnings themselves — which beat expectations — but an imminent and massive lock-up expiration scheduled for March 13, 2026, when approximately 390 million shares of Class A common stock become eligible for public sale.
PATH shares fell approximately 10% in premarket trading on March 12, 2026, reversing the prior session's 6.82% gain, as investors digested Q4 fiscal 2026 earnings released after the close on March 11. The primary catalyst for the selloff was disappointing FY2027 revenue guidance, which implies approximately 8–9% top-line growth — a notable deceleration from the 13% growth delivered in FY2026.
TIC shares are down approximately 15% in premarket trading on March 12, 2026, ahead of the regular session open. Primary catalyst: TIC Solutions reported Q4 2025 earnings before market open, posting an adjusted loss of $0.25 per share — a miss of $0.33 against the analyst consensus of -$0.08 per share.
HIMX shares surged approximately +33% in premarket trading on March 12, 2026, with the stock climbing from a prior close of $9.15 to around $12.19–$12.56. The primary catalyst is a renewed wave of AI-driven semiconductor enthusiasm surrounding Himax's Co-Packaged Optics (CPO) technology and its potential role as a supplier to major players including NVIDIA and Taiwan Semiconductor Manufacturing.
GIII shares fell approximately 15.65% in early trading on March 12, 2026, after the company reported its fiscal Q4 and full-year 2026 earnings before the bell. Q4 net sales dropped 8.1% year-over-year to $771.5 million, missing Wall Street's consensus estimate of approximately $792 million.
LWLG shares surged approximately 42% in early trading on March 12, 2026, building on a 15% rally from the prior session, as the stock's multi-day momentum accelerated into the regular open. The primary catalyst is Lightwave Logic's newly announced silicon photonics development agreement with Tower Semiconductor (TSEM), integrating its electro-optic polymer modulator technology into Tower's PH18 platform.
IperionX (NASDAQ: IPX) shares fell approximately 15% in Thursday's session, with the ADR trading around $42.70 after closing at $50.26 the prior session. The primary catalyst was the company's half-year financial report (H1 FY2026, ending December 31, 2025), which revealed a sharply wider net loss of US$34.8 million — more than double the US$16.2 million loss reported in the prior corresponding period.
SITM shares are down approximately 10% in Thursday's trading session, extending a multi-week decline from February highs near $447. The primary catalyst is a broad-based semiconductor sector selloff driven by intensifying tariff fears and macro uncertainty under the Trump administration's escalating trade policy.
RHLD shares dropped over 24% today, accelerating a recent downtrend that had already left the stock roughly 15–17% lower over the past month before today’s earnings‑driven selloff. For 2025, Resolute reported sales of about $462 million, up modestly from the prior year, but its net loss widened to roughly $5.9 million versus a $2.3 million loss in 2024.
VEON shares fell more than 14% today, a sharp reversal that follows a 12‑month gain of roughly 120% and year‑to‑date return near 45%, leaving the stock vulnerable to profit‑taking.​ The move comes just one day before VEON is scheduled to release its Q4 and full‑year 2025 results, prompting pre‑earnings de‑risking from traders who had enjoyed substantial gains.​
Applied Optoelectronics (AAOI) Stock Falls Over -14% as Overheated Rally Meets Profit-Taking and Valuation Jitters